Speaker 2: Pierre Blier, Canada

Speaker 3: Hiroyuki Uchida, Japan

My talk will focus on the use of the new ECNP nomenclature system to explain the mechanisms of actions of drugs for anxiety and insomnia so that prescribers have a better understanding of their modes of actions and adverse effects

Speaker 1: David Nutt, UK

My talk will focus on the use of the new ECNP nomenclature system to explain the mechanisms of actions of drugs for anxiety and insomnia so that prescribers have a better understanding of their modes of actions and adverse effects

Clarification regarding generic substitution for psychotropic drugs.

PS222. Ketamine Exerts a Prolonged Reduction in Suicidal Ideation Independent of its Antidepressant Effects

s | 81 of 10000 lux would have much less impact on Indian subjects. 2. Ethnicity – in both studies the subjects were born and spent considerable time in their own respective country. 3. Cultural variations in the food consumed usually by the subjects in respective countries.

Reviewers for Neuropsychiatric Disease and Treatment, Volume 1, 2005

The Editor-in-Chief would like to acknowledge the help of the following in reviewing papers published in Volume 1 of Neuropsychiatric Disease and Treatment.